← Back to signals
HAE
STRONG BUYHaemonetics Corporation
Health Care
0.33
PEGY ratio
Rank #116
Why This Matters
This stock appears significantly undervalued relative to its growth and dividend yield. Strong projected growth of 45.8% annually over 5 years.
HAE is trading at 15.0x earnings against 45.8% growth (no dividend), giving a PEGY of 0.33. The math suggests the stock is significantly undervalued relative to its growth and income profile.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
Scan date: 2026-05-08
Valuation
15.0x
P/E Ratio
Growth
45.8%
5yr EPS
Income
0.0%
Div Yield
PEGY Components
PEGY Score0.33
Denominator45.8%
EPS (TTM)$3.63
Market Data
Price$54.37
ExchangeNYSE
S&P 500
What Changed
PEGY Score
0.36→0.33(-0.03)
Rank
#136→#116(+20 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only